ANIX
$3.57
Net Profits | $-2.51Mn |
Anixa Biosciences, Inc.’s net profit jumped 8.56% since last year same period to $-2.51Mn in the Q3 2023. On a quarterly growth basis, Anixa Biosciences, Inc. has generated -23.39% fall in its net profits since last 3-months.
EPS Estimate Current Quarter | -0.09 |
EPS Estimate Current Year | -0.09 |
Anixa Biosciences, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.09 - a 25% jump from last quarter’s estimates.
Anixa Biosciences, Inc.’s earning per share (EPS) estimates for the current year stand at -0.09.
Earning Per Share (EPS) | 0 |
Anixa Biosciences, Inc.’s earning per share (EPS) jumped NaN% since last year same period to 0 in the Q4 2023. This indicates that the Anixa Biosciences, Inc. has generated NaN% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-03-17 | -0.16 | 0 | 100% |
2023-06-14 | -0.16 | 0 | 100% |
2023-09-06 | -0.12 | 0 | 100% |
2024-01-03 | -0.09 | 0 | 100% |